US 10449210
Prodrug compounds and their uses
granted A61KA61K31/661A61K31/6615
Quick answer
US patent 10449210 (Prodrug compounds and their uses) held by Ligand Pharmaceuticals Incorporated expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/661, A61K31/6615, A61K31/663, A61K31/675